Robert A. Kehoe

Robert Arthur Kehoe was a highly influential American toxicologist. Toxicology is the scientific study of how chemicals affect living organisms. Kehoe became a dominant figure in the field of occupational health. This field examines how working environments impact the well-being of employees. For much of the 20th century, Kehoe acted as the primary medical voice for the lead industry. He specifically advocated for the use of tetraethyllead, or TEL, as a gasoline additive. His work shaped public health policy and industrial standards for decades.

Kehoe's career was deeply connected to the production of TEL. In 1921, researchers Charles Kettering and Thomas Midgley Jr. discovered that TEL acted as an anti-knocking agent. This chemical prevented engines from making a knocking sound, which allowed for higher compression ratios. Following this discovery, General Motors and Standard Oil of New Jersey formed the Ethyl Gasoline Corporation. However, workers at TEL plants began to fall ill. Some even died from lead poisoning. To address these health concerns, Kettering hired Kehoe to develop safety protocols for workers handling the chemical.

In 1925, Kehoe helped establish a specific logic for handling industrial safety. This approach is often called the "Kehoe Rule." During a government conference, Kehoe argued that TEL should only be stopped if actual danger could be proven with facts. He believed that products with economic benefits should not be discarded based on mere opinions. This rule shifted the burden of proof onto those who argued against the chemical. Instead of companies proving a product was safe, opponents had to prove it was definitely harmful. This created a high bar for any safety regulations to be passed.

This rule also balanced public health against economic interests. Advocates argued that TEL provided significant benefits, such as fuel conservation. The Kehoe Rule assumed that in the absence of clear evidence of risk, there was no significant risk. This was the opposite of the "precautionary principle." The precautionary principle suggests that a substance might be risky until it is proven safe. By using the Kehoe Rule, the lead industry could continue to profit while scientists spent decades searching for conclusive proof of harm. This strategy was later used by industries involving tobacco, asbestos, and pesticides.

Kehoe maintained a massive influence over scientific data for nearly fifty years. In 1930, he became the director of the Kettering Laboratory of Applied Physiology at the University of Cincinnati. This was the first university-based laboratory dedicated to industrial toxicology. The lab was funded by major stakeholders, including General Motors, DuPont, and the Ethyl Corporation. Because most research on lead was channeled through Kehoe, he held an almost complete monopoly on information. He claimed that low levels of lead in humans were normal and not harmful. His findings were supported by the U.S. Public Health Service and the American Medical Association.

His dominance began to fade due to new scientific evidence. In 1965, a scientist named Clair Patterson published research that challenged Kehoe's views. Patterson argued that global lead contamination was increasing significantly. He traced this acceleration to the use of leaded gasoline following the Industrial Revolution. Patterson's work showed that lead was spreading throughout the entire environment. While it took many years and more precise research to validate these findings, the scientific community eventually moved away from Kehoe's conclusions. His research is now widely considered discredited by the scientific community.

Today, the impact of Kehoe's era is visible in global environmental policy. By 2014, a majority of the world's countries had stopped using leaded gasoline in cars. However, some uses remain, such as fuel for private aviation in the United States. Kehoe's legacy serves as a major case study in how scientific uncertainty can be used in industrial settings. He lived a long life, passing away in Cincinnati in 1992 at the age of 99. His career remains a significant example of the complex relationship between industry, science, and public health.